Danaher Corp (DHR)

Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell

$192.34

Buy

$192.49

arrow-down$-0.65 (-0.34%)

Danaher Corp designs, manufactures and markets professional, medical, industrial and commercial products and services. It markets its products under the brand of Beckman Coulter, Aperio, Dexis, Chemtreat and others.
Prices updated at 05 Jun 2025, 19:06 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-down-0.2%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Income statement

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
15,519m17,049m17,911m22,284m24,802m26,643m23,890m23,875m
8,571m9,505m9,984m12,475m15,239m16,188m14,034m14,206m
2,572m3,055m3,269m4,231m6,387m7,536m5,202m4,863m
16.5817.9218.2518.9925.7528.2921.7720.37
2,492m2,651m3,008m3,646m6,433m7,209m4,764m3,899m
3,800m4,277m4,602m6,545m8,804m9,482m7,496m7,276m
Sales, General and administrative5,043m5,391m5,589m6,896m6,807m7,124m7,329m7,759m
Interest expenses140m137m108m275m231m204m286m278m
Provision for income taxes371m556m873m849m1,064m818m823m747m
Operating expenses5,999m6,450m6,715m8,244m8,852m8,652m8,832m9,343m
Income before taxes2,543m2,962m3,305m4,495m6,511m7,146m5,044m4,646m
Net income available to common shareholders2,492m2,651m2,940m3,510m6,269m7,103m4,743m3,899m
3.583.784.114.978.779.86.445.33
Net interest income-133m-128m31m-204m-220m-163m17m-161m
Advertising and promotion--------
Net investment income, net--------
Realised capital gains (losses), net--------
Total benefits, claims and expenses--------
Earnings per share (diluted)3.533.744.054.898.619.666.385.29
Free cash flow per share3.80194.23464.63536.17879.62099.5879.14536.7125
Book value/share36.427539.449444.432448.795156.262.22370.896971.3378
Debt equity ratio0.391810.3433880.7727670.602170.55030.4101710.3301990.332398

Balance sheet

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Current assets6,850m7,094m25,597m13,802m11,648m15,883m13,937m9,497m
Current liabilities4,792m4,842m4,932m7,402m8,140m8,389m8,274m6,798m
Total capital36,686m37,903m51,787m60,959m67,335m69,168m70,193m65,043m
Total debt10,522m9,740m22,526m22,178m23,272m20,739m19,536m17,146m
Total equity26,358m28,214m30,271m39,766m45,167m50,082m53,486m49,543m
Total non current liabilities--------
Loans10,327m9,689m21,517m21,193m22,168m19,086m16,707m15,500m
Total assets46,649m47,833m62,082m76,161m83,184m84,350m84,488m77,542m
Total liabilities--------
Cash and cash equivalents630m788m19,912m6,035m2,586m5,995m5,864m2,078m
Common stock697m701m696m711m715m728m739m719m

Cash flow

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Cash at beginning of period964m630m788m19,912m6,035m2,586m5,995m5,864m
Cash dividends paid-378m-433m-751m-615m-742m-818m-1,248m-768m
2,858m3,366m3,316m5,417m7,064m7,367m5,781m5,296m
Investments (gains) losses-843m-2,949m-1,238m-21,239m-12,987m-2,234m-7,081m-1,981m
630m788m19,912m6,035m2,586m5,995m5,864m2,078m
Net income--------
3,478m4,022m3,952m6,208m8,358m8,519m7,164m6,688m
-620m-656m-635m-791m-1,294m-1,152m-1,383m-1,392m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.